Institute of Work, Health and Organisations, University of Nottingham, Nottingham, UK.
Clin Rehabil. 2010 Mar;24(3):211-21. doi: 10.1177/0269215509343492. Epub 2009 Dec 21.
The aim was to evaluate a group treatment for people with multiple sclerosis and low mood.
Randomized controlled trial.
Community.
Patients with multiple sclerosis and low mood, scoring >7 on the Hospital Anxiety and Depression Scales or >2 on the General Health Questionnaire 12.
Participants either attended an adjustment group for six, 2-hour group treatment sessions or were on a waiting list to attend the group.
Hospital Anxiety and Depression Scale, General Health Questionnaire 12, Multiple Sclerosis Self Efficacy Scale, Multiple Sclerosis Impact Scale and Short Form 36 administered 3 and 6 months after random allocation.
Of the 219 patients identified, 100 (46%) reported depressive symptoms and 126 (58%) anxiety symptoms. Forty participants were recruited, aged 25-68 (mean 47.7 SD 9.7) and eight were men. Patients allocated to the group intervention reported fewer depressive symptoms than those in the control group (U 109.5, P<0.05) but there were no significant differences in anxiety symptoms, self-efficacy or quality of life.
Depressive symptoms were reduced following group intervention, which suggests this may be an effective psychological treatment and warrants further evaluation.
评估一种针对多发性硬化症伴情绪低落患者的团体治疗方法。
随机对照试验。
社区。
多发性硬化症伴情绪低落、医院焦虑抑郁量表评分>7 或一般健康问卷 12 评分>2 的患者。
参与者参加为期 6 次、每次 2 小时的调整团体治疗组或在等待名单上等待参加团体治疗。
在确定的 219 名患者中，有 100 名（46%）报告有抑郁症状，126 名（58%）有焦虑症状。招募了 40 名参与者，年龄 25-68 岁（平均 47.7±9.7），其中 8 名为男性。与对照组相比，接受团体干预的患者报告的抑郁症状较少（U=109.5，P<0.05），但焦虑症状、自我效能感或生活质量无显著差异。
团体干预后抑郁症状有所减轻，这表明这可能是一种有效的心理治疗方法，值得进一步评估。
